Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 17,976 | 17,993 | 22,934 | 22,099 | 30,732 |
| Cost of Goods | 6,070 | 6,300 | 6,731 | 7,315 | 12,168 |
| Gross Profit | 11,906 | 11,693 | 16,203 | 14,784 | 18,564 |
| Operating Expenses | 15,626 | 14,457 | 14,570 | 16,603 | 18,563 |
| Operating Income | -3,650 | -2,464 | 2,364 | -1,504 | 169 |
| Other Income | -272 | -178 | -1,756 | -6,616 | -2,626 |
| Pre-tax Income | -3,922 | -2,642 | 608 | -8,120 | -2,457 |
| Income Tax | 695 | 245 | 828 | N/A | N/A |
| Net Income Continuous | -4,617 | -2,887 | -220 | -8,120 | -2,457 |
| Net Income | $-4,617 | $-2,887 | $-220 | $-8,120 | $-2,457 |
| EPS Basic Total Ops | -0.82 | -0.52 | -0.04 | -1.48 | -0.75 |
| EPS Basic Continuous Ops | -0.82 | -0.52 | -0.04 | -1.48 | -0.74 |
| EPS Diluted Total Ops | -0.82 | -0.52 | -0.04 | -1.48 | -0.75 |
| EPS Diluted Continuous Ops | -0.82 | -0.52 | -0.04 | -1.48 | -0.74 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.52 | -0.04 | -1.48 | 0.16 |
| EBITDA(a) | $-1,572 | $-384 | $4,697 | $874 | $2,431 |